Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110. 2003

Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
Pharmaceutical Screening Research Team, Korea Research Institute of Chemical Technology, 100 Jang-Dong, Yusong-Gu, Daejon 305-343, South Korea.

1-(2-ethoxy-phenyl)-4-[3-(3-thiophen-2-yl-isoxazolin-5-yl)-propyl]-piperazine (KCH-1110), has a high affinity for human dopamine D3 (hD3) receptor (Ki=1.28 nM) with about 90-fold selectivity over the human dopamine D2L (hD2L) receptor. Antipsychotic or antidopaminergic activity of KCH-1110 was investigated in the models for the positive symptoms of schizophrenia, apomorphine-induced climbing and cocaine-induced hyperlocomotion, in mice. Intraperitoneal (i.p.) or oral (p.o.) administration of KCH-1110 potently inhibited the apomorphine-induced cage climbing without any rotarod ataxia in mice. Cocaine-induced hyperactivity was also antagonised by KCH-1110. In addition, KCH-1110 attenuated the hypothermia induced by a selective dopamine D3 agonist, 7-OH-DPAT in mice. KCH-1110 did not induce catalepsy in mice, but at much higher doses only a slight catalepsy response was shown. Although high doses of KCH-1110 significantly enhanced serum prolactin secretion in rats, low dose of KCH-1110 did not increase prolactin levels in rats. The present studies, therefore, suggest that KCH-1110 is a potent and relatively selective dopamine D3 receptor antagonist with antipsychotic actions.

UI MeSH Term Description Entries
D007035 Hypothermia Lower than normal body temperature, especially in warm-blooded animals. Hypothermia, Accidental,Accidental Hypothermia,Accidental Hypothermias,Hypothermias,Hypothermias, Accidental
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D002375 Catalepsy A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions. Cerea Flexibilitas,Flexibility, Waxy,Anochlesia,Anochlesias,Catalepsies,Flexibilitas, Cerea,Flexibilities, Waxy,Waxy Flexibilities,Waxy Flexibility
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
January 2007, CNS drug reviews,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
September 2000, The Journal of pharmacology and experimental therapeutics,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
August 1985, The Journal of pharmacology and experimental therapeutics,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
July 1999, Bioorganic & medicinal chemistry letters,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
February 1998, Pharmacology, biochemistry, and behavior,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
October 1986, The Journal of pharmacy and pharmacology,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
November 2010, Science (New York, N.Y.),
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
December 1996, The Journal of pharmacology and experimental therapeutics,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
November 1994, European journal of pharmacology,
Woo-Kyu Park, and Daeyoung Jeong, and Cheol-Won Yun, and Sunghou Lee, and Heeyeong Cho, and Gun-Do Kim, and Hun Yeong Koh, and Ae Nim Pae, and Yong Seo Cho, and Kyung Il Choi, and Ji Young Jung, and Sun Ho Jung, and Jae Yang Kong
May 2017, Scientific reports,
Copied contents to your clipboard!